FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W2802115105> ?p ?o ?g. }

• W2802115105 endingPage "462" @default.
• W2802115105 startingPage "443" @default.
• W2802115105 abstract "As biopharmaceutical companies have optimized cell line and production culture process development, titers of recombinant antibodies have risen steadily to 3–8 g/L for fed-batch mammalian cultures at production scales of 10 kL or larger. Most new antibody products are produced from Chinese Hamster Ovary (CHO) cell lines, and there are relatively few alternative production hosts under active evaluation. Many companies have adopted a strategy of using the same production cell line for early clinical phases as well as commercial production, which reduces the risk of product comparability issues during the development lifecycle. Product quality and consistency expectations rest on the platform knowledge of the CHO host cell line and processes used for the production of many licensed antibodies. The lack of impact of low-level product variants common to this platform on product safety and efficacy also builds on the established commercial history of recombinant antibodies, which dates back to 1997. Efforts to increase titers further will likely yield diminishing returns. Very few products would benefit significantly from a titer greater than 8 g/L; in many cases, a downstream processing bottleneck would preclude full recovery from production-scale bioreactors for high titer processes. The benefits of a process platform based on standard fed-batch production culture include predictable scale-up, process transfer, and production within a company’s manufacturing network or at a contract manufacturing organization. Furthermore, the confidence in an established platform provides key support towards regulatory flexibility (e.g., design space) for license applications following a quality-by-design strategy. These factors suggest that novel technologies for antibody production may not provide a substantial return on investment. What, then, should be the focus of future process development efforts for companies that choose to launch antibody products using their current platform? This review proposes key focus areas in an effort to continually improve process consistency, assure acceptable product quality, and establish appropriate process parameter limits to enable flexible manufacturing options." @default.
• W2802115105 created "2018-05-17" @default.
• W2802115105 creator A5005615300 @default.
• W2802115105 creator A5071206494 @default.
• W2802115105 creator A5081589870 @default.
• W2802115105 date "2018-01-01" @default.
• W2802115105 modified "2023-09-30" @default.
• W2802115105 title "A Different Perspective: How Much Innovation Is Really Needed for Monoclonal Antibody Production Using Mammalian Cell Technology?" @default.
• W2802115105 cites W1600742442 @default.
• W2802115105 cites W1608393523 @default.
• W2802115105 cites W1800577740 @default.
• W2802115105 cites W1870974274 @default.
• W2802115105 cites W1924851260 @default.
• W2802115105 cites W1942150801 @default.
• W2802115105 cites W1950250567 @default.
• W2802115105 cites W1987319291 @default.
• W2802115105 cites W1995049749 @default.
• W2802115105 cites W2006947259 @default.
• W2802115105 cites W2019613871 @default.
• W2802115105 cites W2035970342 @default.
• W2802115105 cites W2038855950 @default.
• W2802115105 cites W2045067253 @default.
• W2802115105 cites W2060204419 @default.
• W2802115105 cites W2071705963 @default.
• W2802115105 cites W2080085849 @default.
• W2802115105 cites W2085423295 @default.
• W2802115105 cites W2099684692 @default.
• W2802115105 cites W2106691841 @default.
• W2802115105 cites W2108160491 @default.
• W2802115105 cites W2111594360 @default.
• W2802115105 cites W2116548552 @default.
• W2802115105 cites W2134238361 @default.
• W2802115105 cites W2134518608 @default.
• W2802115105 cites W2141178114 @default.
• W2802115105 cites W2146981871 @default.
• W2802115105 cites W2147078037 @default.
• W2802115105 cites W2149717386 @default.
• W2802115105 cites W2149951642 @default.
• W2802115105 cites W2152850495 @default.
• W2802115105 cites W2155220498 @default.
• W2802115105 cites W2172134808 @default.
• W2802115105 cites W2174275312 @default.
• W2802115105 cites W2254007717 @default.
• W2802115105 cites W2314404739 @default.
• W2802115105 cites W2333170395 @default.
• W2802115105 cites W2399070630 @default.
• W2802115105 cites W2480937959 @default.
• W2802115105 cites W2742450562 @default.
• W2802115105 cites W2770546054 @default.
• W2802115105 doi "https://doi.org/10.1007/10_2018_59" @default.
• W2802115105 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/29721583" @default.
• W2802115105 hasPublicationYear "2018" @default.
• W2802115105 type Work @default.
• W2802115105 sameAs 2802115105 @default.
• W2802115105 citedByCount "19" @default.
• W2802115105 countsByYear W28021151052018 @default.
• W2802115105 countsByYear W28021151052019 @default.
• W2802115105 countsByYear W28021151052020 @default.
• W2802115105 countsByYear W28021151052021 @default.
• W2802115105 countsByYear W28021151052022 @default.
• W2802115105 countsByYear W28021151052023 @default.
• W2802115105 crossrefType "book-chapter" @default.
• W2802115105 hasAuthorship W2802115105A5005615300 @default.
• W2802115105 hasAuthorship W2802115105A5071206494 @default.
• W2802115105 hasAuthorship W2802115105A5081589870 @default.
• W2802115105 hasConcept C127413603 @default.
• W2802115105 hasConcept C139719470 @default.
• W2802115105 hasConcept C144133560 @default.
• W2802115105 hasConcept C150903083 @default.
• W2802115105 hasConcept C162324750 @default.
• W2802115105 hasConcept C162853370 @default.
• W2802115105 hasConcept C175656101 @default.
• W2802115105 hasConcept C19351080 @default.
• W2802115105 hasConcept C204320433 @default.
• W2802115105 hasConcept C2778348673 @default.
• W2802115105 hasConcept C2781047461 @default.
• W2802115105 hasConcept C54355233 @default.
• W2802115105 hasConcept C81885089 @default.
• W2802115105 hasConcept C86803240 @default.
• W2802115105 hasConceptScore W2802115105C127413603 @default.
• W2802115105 hasConceptScore W2802115105C139719470 @default.
• W2802115105 hasConceptScore W2802115105C144133560 @default.
• W2802115105 hasConceptScore W2802115105C150903083 @default.
• W2802115105 hasConceptScore W2802115105C162324750 @default.
• W2802115105 hasConceptScore W2802115105C162853370 @default.
• W2802115105 hasConceptScore W2802115105C175656101 @default.
• W2802115105 hasConceptScore W2802115105C19351080 @default.
• W2802115105 hasConceptScore W2802115105C204320433 @default.
• W2802115105 hasConceptScore W2802115105C2778348673 @default.
• W2802115105 hasConceptScore W2802115105C2781047461 @default.
• W2802115105 hasConceptScore W2802115105C54355233 @default.
• W2802115105 hasConceptScore W2802115105C81885089 @default.
• W2802115105 hasConceptScore W2802115105C86803240 @default.
• W2802115105 hasLocation W28021151051 @default.
• W2802115105 hasLocation W28021151052 @default.
• W2802115105 hasOpenAccess W2802115105 @default.
• W2802115105 hasPrimaryLocation W28021151051 @default.
• W2802115105 hasRelatedWork W1915519529 @default.

• next